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https://doi.org/10.1016/j.jacl.2019.09.0BACKGROUND: South Asians are more prone to develop atherosclerotic cardiovascular disease
(ASCVD) compared with white Caucasians, which is not fully explained by classical risk factors.
We recently reported that the presence of aggregation-prone low-density lipoprotein (LDL) in the cir-
culation is associated with increased ASCVD mortality.
OBJECTIVE: We hypothesized that LDL of South Asians is more prone to aggregate, which may be
explained by differences in their LDL lipid composition.
METHODS: In this cross-sectional hypothesis-generating study, LDL was isolated from plasma of
healthy South Asians (n 5 12) and age- and BMI-matched white Caucasians (n 5 12), and its aggre-
gation susceptibility and lipid composition were analyzed.
RESULTS: LDL from South Asians was markedly more prone to aggregate compared with white
Caucasians. Among all measured lipids, sphingomyelin 24:0 and triacylglycerol 56:8 showed the high-
est positive correlation with LDL aggregation. In addition, LDL from South Asians was enriched in
arachidonic acid containing phosphatidylcholine 38:4 and had less phosphatidylcholines and choles-
teryl esters containing monounsaturated fatty acids. Interestingly, body fat percentage, which wase applied for a patent on the LDL
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Ruuth et al LDL aggregation and ethnicity 911higher in South Asians (126%), positively correlated with LDL aggregation and highly positively
correlated with triacylglycerol 56:8, sphingomyelin 24:0, and total sphingomyelin.
CONCLUSIONS: LDL aggregation susceptibility is higher in healthy young South Asians compared
with white Caucasians. This may be partly explained by the higher body fat percentage of South Asians,
leading to sphingomyelin enrichment of LDL.We anticipate that the presence of sphingomyelin-rich, ag-
gregation-prone LDLparticles in young SouthAsiansmay increase LDL accumulation in the arterial wall
and thereby contribute to their increased risk of developing ASCVD later in life.
 2019 National Lipid Association. Published by Elsevier Inc. This is an open access article under the CC
BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
Atherosclerotic cardiovascular disease (ASCVD) is the
primary cause of death worldwide and brings a major
burden on global health care.1 People originating from the
South Asian subcontinent (India, Nepal, Bangladesh,
Bhutan, Pakistan, and Sri Lanka), who comprise one-
fourth of the world population, are particularly prone to
develop ASCVD compared with other ethnic groups.2
Moreover, South Asians suffer from higher ASCVD
morbidity and mortality rates and experience their first
myocardial infarction on average 10 years before Western
white Caucasians.3 Factors contributing to this ASCVD
risk that are highly present in the South Asian population
include smoking, a low level of physical activity, and a
diet enriched with carbohydrates and saturated fats. In
addition to these lifestyle factors, South Asians have a
high body fat percentage and are susceptible to develop
obesity, insulin resistance, hypertension, and dyslipidemia.
However, the high ASCVD risk of South Asians cannot be
solely explained by a high prevalence of classical risk fac-
tors in this population.4–6
Even though a high plasma low-density lipoprotein
(LDL) cholesterol level is a risk factor for ASCVD,7 mea-
surement of LDL cholesterol levels only does not capture
the qualitative properties of LDL particles affecting the
progression of atherosclerosis.8 Current theories of athero-
genesis emphasize retention of LDL by the subendothelial
proteoglycans in the arterial intima as an initial step.9 The
retained LDL is susceptible to modification by oxidation,
glycation, and proteolytic and lipolytic enzymes,10 which
can induce aggregation of the modified LDL particles.11
An enzyme that induces formation of extremely large
LDL aggregates is sphingomyelinase.12–15 LDL aggrega-
tion enhances its binding to arterial proteoglycans11 and
thereby can increase extracellular lipid accumulation,
and further aggravate atherosclerosis development.16 In
addition, macrophages and other inflammatory cells can
take up aggregated LDL particles, leading to foam cell
formation.17 Over decades, these processes result in for-
mation of atherosclerotic lesions containing aggregated
LDL-derived particles.13,18–20 We have recently developed
a method to measure the susceptibility of LDL particles
isolated from plasma to aggregate and observed substan-
tial interindividual variation in LDL aggregation.21Importantly, LDL aggregation susceptibility was found
to predict future cardiovascular deaths independent of
conventional risk factors for ASCVD, such as LDL
cholesterol levels.21
Differences in the aggregation susceptibility of LDL
particles depend on their surface lipid composition. We
observed that LDL particles having a high proportion of
sphingomyelins (SMs) and ceramides are prone to aggregate,
whereas LDL particles having a relatively high content of
phosphatidylcholines (PCs) and lysophosphatidylcholines
(LPCs) are more resistant to aggregation.21 These data are in
accordance with studies showing that plasma SM levels are
higher in patients having coronary artery disease than in con-
trols22 and that plasma ceramides predict future cardiovascu-
lar deaths.23,48 Of LDL core lipids, a high proportion of
several triacylglycerol (TAG) species and cholesteryl esters
(CEs) containing monounsaturated fatty acids was associ-
ated with decreased LDL aggregation.21
In this study, we hypothesized that, compared with age-
and BMI-matched white Caucasians, the susceptibility of
LDL to aggregate is higher in healthy South Asian in-
dividuals, which could partly contribute to their increased
risk to develop ASCVD later in life. In addition, because we
have previously shown that LDL aggregation is associated
with specific characteristics of the LDL lipidome, we
hypothesized that such a difference in LDL aggregation
would be mirrored by differences in LDL lipid composition
between South Asians and white Caucasians. Finally, as
South Asians have relatively more body fat than BMI-
matched white Caucasians, and obesity is associated with
higher levels of sphingolipids, including both SM and
ceramide,24we assessedwhether body composition is related
to both the aggregation susceptibility and lipidome of LDL.Methods
Participants
Twelve healthy Dutch South Asian and twelve Dutch
white Caucasian men were matched for age (18–32 years)
and BMI (18–27 kg/m2) and were included in this study.
South Asian subjects were eligible in case of being born
and raised in the Netherlands and having 4 grandparents
from South Asian descent. Major exclusion criteria
912 Journal of Clinical Lipidology, Vol 13, No 6, December 2019included smoking, recent weight loss, a significant chronic
disease, and/or a renal, hepatic, or endocrine disease. None
of the participant used any medication. The study was per-
formed in accordance with the principles of the revised
declaration of Helsinki and was approved by the medical
Ethical Committee of the Leiden University Medical Cen-
ter in the Netherlands.25 All study participants provided
written informed consent before the study.
Study design
This study was conducted as part of a clinical trial that
investigated the effects of the glucagon-like peptide 1
receptor agonist exenatide on brown adipose tissue activity
and energy metabolism (Janssen & Nahon et al, in
preparation, trial register number clinicaltrials.gov
NCT03002675). The study was conducted between
September 2016 and February 2018 at the Leiden Univer-
sity Medical Center, the Netherlands. In the present study,
we analyzed only samples collected at the baseline. Partic-
ipants had been instructed to refrain from physical exercise
48 hours before the study day. After a 10-hour overnight
fast, body composition was determined by bioimpedance
analysis (Bodystat 1500; Bodystat, Douglas, Isle of Man,
UK) and blood samples were drawn.
Serum and plasma measurements
Commercially available enzymatic kits were used to
measure concentrations of triglycerides, total cholesterol,
high-density lipoprotein (HDL) cholesterol (all Roche Di-
agnostics,Woerden, theNetherlands) and insulin (Meso Scale
Diagnostics LLC, Rockville, MD) in serum, and glucose
(Instruchemie, Delfzijl, the Netherlands) in plasma. LDL
cholesterol was calculated by the Friedewald equation.26
LDL isolation
LDL (d 5 1.019 to 1.063 g/mL) was isolated from
300 mL plasma samples by D2O-based sequential ultracen-
trifugation,27 and 300 mL of LDL was collected. The con-
centration of LDL is expressed as protein concentration,
which was determined using Pierce BCA Protein Assay
Kit (Thermo Scientific, Rockford).
Production of human recombinant acid
sphingomyelinase
The human recombinant acid sphingomyelinase protein
was produced at the University of Helsinki, Finland. The
cDNA was ordered from GenScript (Piscataway, NJ) as
pUC57 plasmid and subcloned to pEFIRES-P vector with an
EF1a promoter28 or to another proprietarymammalian expres-
sion vector with a CAG-promoter. Both plasmid vectors
yielded essentially similar protein expression in Chinese
hamster ovary-S cells.For production of the protein, CHO cells were trans-
fected with the expression construct via lipofection (Fugene
6; Promega, Madison, WI) and selected with puromycin
(Corning, Manassas, VA). During selection, cells were
grown in F12 (Sigma-Aldrich, St. Louis, MO) supple-
mented with 2 mmol/L UltraGlutamine (Lonza, Verviers,
Belgium), 100 mL/mL streptomycin, 100 IU/mL penicillin
(Corning, Mediatech Inc, Manassas, VA) and 10% FBS
(Gibco, Life Technologies, Paisley, UK). For large-scale
expression, cells were adapted to CD OptiCHO medium
(Gibco, Life Technologies, Paisley, UK) supplemented with
2 mmol/L UltraGlutamine and grown in suspension in an
orbital shaker. Cell culture supernatants were clarified by
filtration through 0.22 mm membranes (Steritop, Millipore,
Darmstadt, Germany) and the solution was pumped through
a Protino column (Macherey-Nagel, Duren, Germany). The
protein was eluted with imidazole, dialyzed against
140 mM NaCl, and finally concentrated with Amicon Ultra
concentrator (30 kDa MWCO, Millipore Ireland Ltd,
Tullagreen, Ireland).
LDL aggregation susceptibility measurement
The measurement of LDL aggregation susceptibility was
performed essentially as described before.21 Briefly, iso-
lated LDL particles were diluted to 200 mg/mL in 20 mM
MES, pH 5.5, containing 150 mM NaCl and 50 mM
ZnCl2. The size of the LDL particles was measured (0 h)
using dynamic light scattering (Wyatt DynaPro Plate
Reader II; Wyatt Technology, CA). Sphingomyelinase
was added to the wells and the wells were coated with
paraffin oil. Particle aggregation was followed by
measuring their size approximately every 15 minutes for
6 hours. Aggregation data were collected with Dynamics
V7 software (Wyatt Technology, CA).
Lipid mass spectrometry analyses
For mass spectrometry (MS), total lipids of the blood
plasma LDL isolates were extracted into chloroform accord-
ing to Folch et al.29 Before MS analysis, aliquots of the lipid
extracts were dissolved in chloroform/methanol (1:2 v/v) and
spiked with the quantitative internal standard mixture de-
signed for human plasma lipids (SPLASH LIPIDOMIX
Mass Spec Standard No 330707; Avanti Polar Lipids, Inc.,
AL). This mixture contained separate deuterium-labeled
standard compounds with exact concentration for each of
the LDL lipid classes, which thus were quantified against
their own standards having similar efficiency of detection
as the natural lipid species in LDL. Just before the analysis,
NH4OH was added to sample aliquots (to give 1% solution
by vol) to support ionization and prevent sodium adduct for-
mation. The sample solutions were infused via a syringe
pump into the electrospray ionization (ESI) source of a triple
quadrupole mass spectrometer (Agilent 6490 Triple Quad
LC/MS; Agilent Technologies, Inc., Santa Clara, CA) at a
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TAG species as (M1NH4)
1 ions,30 whereasMS/MS precur-
sor ion scans were used to detect PC, LPC, and SM species
(precursors of m/z 184) and CE species (precursors of m/z
369). The ESI-MS/MS instrument was set to a source tem-
perature of 250C and collision energies of 10–30 eV (opti-
mized for each lipid class) were used. Nitrogen was used as
the collision, nebulizing (20 psi) as well as drying gas (11mL/
min). Data analysis of the mass spectra were performed by
using MassHunter Workstation qualitative analysis software
(Agilent Technologies, Inc.) and the individual lipid species
were quantified using the internal standards and Lipid Mass
SpectrumAnalysis software.31 The concentrations generated
by Lipid Mass Spectrum Analysis were converted to molar
percentage data. In addition, the acyl chain assemblies in
such TAG and PC species that clearly separated the South
Asian and white Caucasian samples were studied by
recording their acyl chain–specific MS/MS fragments.32
For TAG species, positive ion mode neutral loss scans of
different acyl chains were detected. For PC species, their
formate adducts served as mother ions for negative ion
mode precursor scans of the acyl fragments.
Statistical analyses
Raw data of LDL aggregate size was analyzed with
GraphPad Prism (version 8.0.1; GraphPad Software, La
Jolla, CA). Owing to limitations of dynamic light scattering
sensitivity for large particles, the maximum aggregate size
was limited to 3000 nm and the minimum size to 14 nm.
LDL aggregation curves were fitted with nonlinear regres-
sion curve fit ([Agonist] vs response–variable slope [4
parameters]) and aggregate size at the 2-h time point was
interpolated.
The results are presented as mean 6 SD and the
statistical significance between groups was determined by
unpaired Student’s t-test or by Mann-Whitney test. These
tests and two-tailed Spearman correlation coefficient anal-
ysis were performed using IBM SPSS Software (version
25.0, North Castle, NY). P-values, .05 were considered to
be significant. Correlation analyses were performed for the
total study population as well as per ethnicity. In addition,
the PC species profiles of the LDL isolates were subjected
to principal component analysis using Sirius, PRS, Bergen,
Norway (version 8.5). False discovery rate (FDR) was
controlled by using 2-stage step-up method of Benjamini,
Krieger and Yekutieli using GraphPad Prism.Results
Baseline characteristics
Twelve healthy Dutch men of South Asian descent and
twelve age- and BMI-matched white Caucasian men
participated in this study. Table 1 shows the clinicalcharacteristics of the participants. Compared with white
Caucasians, South Asians had a higher body fat percentage
(18.9 6 3.2 vs 14.5 6 4.7%, P 5 .015, unpaired Student’s
t-test) at a similar BMI (24.7 6 2.7 vs 23.9 6 2.4 kg/m2,
P 5 .47). There were no significant differences between
ethnicities in plasma glucose and serum insulin, triglycer-
ides, HDL cholesterol, or LDL cholesterol, whereas serum
total cholesterol was higher in South Asians than in white
Caucasians (4.8 6 0.8 vs 4.2 6 0.5 mmol/L, P 5 .032).
LDL from South Asians is more prone to
aggregate than LDL from white Caucasians
To determine if LDL of South Asians is more prone to
aggregate than LDL of white Caucasians, we isolated LDL
from the plasma samples and measured LDL aggregation
susceptibility. Treatment of LDL with sphingomyelinase
induced rapid formation of large aggregates (Fig. 1A). In
accordance with our earlier report,21 LDL aggregate size
at 2 hours correlated tightly and significantly with the
calculated inflection point of the curve describing the
aggregate size as a function of time (Spearman’s
rho 5 20.905, P 5 1.2 ! 1029) (Fig. 1B and C). There
were no significant differences in the size of LDL particles
in the beginning of the incubation or in the end of the incu-
bation. However, LDL from South Asians aggregated more
rapidly than LDL from white Caucasians, as indicated by a
larger LDL aggregate size at 2 h (620 6 320 nm vs
350 6 290 nm, P 5 .011; Fig. 1D).
LDL lipid composition correlates with LDL
aggregation and differs between the ethnic
groups
LDL particles have an amphiphilic surface monolayer
containing phospholipids and unesterified cholesterol and
a hydrophobic core containing CEs and TAGs. A single
copy of apoB-100 surrounds the particle. Because LDL
lipid composition has been shown to influence the aggre-
gation susceptibility of LDL particles,21 we next analyzed
the LDL lipidome in both ethnicities (n 5 24). Within this
pooled data, SM 23:0, SM 24:0, and TAG 56:8 were asso-
ciated with aggregation-prone LDL, whereas TAG 54:1,
TAG 52:2, and CE 16:0 and CE 18:1 were associated
with aggregation-resistant LDL (Fig. 2A). When the rela-
tive amounts of these lipids in LDL particles were
compared between the 2 ethnic groups, South Asians
had significantly more SM 24:0 and TAG 56:8, 2 lipids
associated with aggregation-prone LDL, and less CE
18:1 and TAG 52:2, 2 lipids that were associated with
aggregation-resistant LDL (Fig. 2B–D). In addition, we
determined associations between LDL lipid composition
and LDL aggregation susceptibility in South Asians and
white Caucasians separately (Supplemental Fig. 1).
Although in South Asians, only LPC 20:3 correlated
with LDL aggregation, in white Caucasians, several lipid
Figure 1 (A) The size distribution of both native LDL and LDL treated with human recombinant sphingomyelinase for 2 h was deter-
mined by dynamic light scattering. (B) LDL aggregation curve (LDL aggregate size (nm) vs time (h)) after inducing aggregation with hu-
man recombinant sphingomyelinase. LDL aggregate size at time point 2 h (365 nm) is marked in the curve as well as the calculated
inflection point (2.74 h). (C) Correlation of LDL aggregate size (nm) at 2 h and the calculated inflection point (h) (Spearman’s
rho 5 0.905, P 5 1.2 ! 1029). (D). LDL particles were isolated from plasma of South Asian men (n 5 12) and white Caucasian men
(n 5 12), treated with sphingomyelinase, and aggregate size was measured using dynamic light scattering. Aggregate size at the 2-h
time point was calculated from aggregation curves. The box plot diagram shows the median and the upper and lower quartiles of the aggre-
gate size at 2 h in both ethnicities, the whiskers presenting the lowest and the highest values. Statistical significances of the differences
between the ethnicities were studied by using Mann-Whitney U test. LDL, low-density lipoprotein.
914 Journal of Clinical Lipidology, Vol 13, No 6, December 2019species correlated with LDL aggregation, including lipids
that positively (TAG 56:8 and SM 24:0) and negatively
(TAG 54:1) correlated with LDL aggregation when ethnic-
ities were combined.
In addition to these lipids that significantly associated
with LDL aggregation, there were also other differences
between the LDL lipidomes of South Asians and white
Caucasians (Fig. 3 and Supplemental Table 1). LDL from
white Caucasians had a higher proportion of 2 highly unsat-
urated PC species; 36:5 and 38:5, but lower proportion of
PC 38:4 (Fig. 3A). The PC species profiles, trait of the
LDL surface, were also studied by multivariate principal
component analysis (Fig. 3B), and also in this analysis,the South Asians were found to have relative enrichment
of PC 38:4 and 36:2, which species contained arachidonic
acid (20:4) and its precursor linoleic acid (18:2), respec-
tively (as evidenced by acyl chain specific MS/MS precur-
sor scans). In addition, several monounsaturated PC species
were present with higher proportions in white Caucasians
(Fig. 3A and B). Of all core lipids, monounsaturated CEs
(16:1 and 18:1) were higher in white Caucasians, whereas
CE 18:2, the most common lipid in LDL, was higher in
South Asians (Fig. 3C). Of note, the elevated TAG 56:8
of South Asians comprised 2 main molecular species
16:0/18:2/22:6 and 16:0/20:4/20:4 (as evidenced by study-
ing the acyl chain specific MS/MS neutral losses from the
Figure 2 (A) Volcano plot showing the Spearman’s correlation coefficients of LDL aggregate size at 2 h (LDL aggregation susceptibility)
vs LDL lipids (n 5 24). Only those lipids with significant P-values (P , .05) are annotated within the figure. Positive correlations are
indicated with red circles and negative correlations with blue circles. (B–D) Scatter plot diagrams (mean 6 SD) showing the proportions
of the (B) surface lipid species (SM, sphingomyelin), (C) core triacylglycerols (TAGs) and (D) core cholesteryl esters (CE), which signif-
icantly correlate with aggregate size at 2 h, in South Asians and white Caucasians. Statistical significances of the differences between the
groups were determined using the unpaired Student’s t-test. The differences remain significant after FDR correction for all lipids with P-
value , .05. FDR, false discovery rate; LDL, low-density lipoprotein.
Table 1 Clinical characteristics of study participants
Clinical characteristics South Asians (n 5 12) White Caucasians (n 5 12) P-value
Age (y) 27.5 6 3.2 25.6 6 3.2
Body mass index (kg/m2) 24.7 6 2.7 23.9 6 2.4
Body fat (%) 18.9 6 3.2 14.5 6 4.7 .015
Systolic blood pressure (mm Hg) 119 6 6 124 6 9
Diastolic blood pressure (mm Hg) 75 6 9 82 6 10
Triglycerides (mg/dL) 73 6 36 73 6 25
Total cholesterol (mg/dL) 186 6 31 162 6 19 .032
HDL cholesterol (mg/dL) 46 6 12 44 6 9
LDL cholesterol (mg/dL) 126 6 35 104 6 15
Insulin (pg/mL) 137 6 133 136 6 89
Glucose (mmol/L) 4.8 6 0.3 4.6 6 0.2
LDL, low-density lipoprotein; HDL, high-density lipoprotein.
Data are presented as mean6 SD. Statistical differences between the ethnicities were determined using the unpaired Student’s t-test, and the P-value
is reported in the case of a statistically significant difference between the South Asians and white Caucasians.
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Figure 3 (A) Relative differences between South Asians and
white Caucasians (((Average South Asians–Average white Cauca-
sians)/Average all) ! 100) in their LDL surface lipids. (B) Phos-
phatidylcholine (PC) species profile differences between the
ethnicities were further demonstrated by PCA using untrans-
formed data (the gray area at the origin of the PCA biplot repre-
sents the location of several species having little separation power
in the analysis). (C) Relative differences between South Asians
and white Caucasians (((Average South Asians–Average white
Caucasians)/Average all) ! 100) in their LDL core lipids. Statis-
tical differences between the groups were determined using the
unpaired Student’s t-test. The difference in LPC 16:0, PC 36:2,
SM 23:1, SM 24:0, TAG 52:2, and TAG 56:8 did not remain
significant after FDR correction. CE, cholesteryl ester; LPC, lyso-
phosphatidylcholine; LDL, low-density lipoprotein; PC, phospha-
tidylcholine; PCA, principal component analysis; SM,
sphingomyelin; TAG; triacylglycerol.
916 Journal of Clinical Lipidology, Vol 13, No 6, December 2019TAG molecule). Of these, the amount of 16:0/18.2/22:6 was
similar in different samples but the amount of the arachi-
donic acid containing varied from sample to sample and
was on average higher in the South Asian samples.Body fat percentage positively correlates with
LDL aggregation susceptibility
Because obesity may modulate ASCVD risk by inducing
alterations in the plasma lipidome, we next examined
whether anthropometric measurements correlated with
LDL lipid components and LDL aggregation. While no
correlation with BMI was observed (data not shown), LDL
aggregate size at 2 h significantly and positively correlated
with body fat percentage (Spearman’s rho 5 0.486,
P 5 .016) (Fig. 4A). Interestingly, a higher body fat per-
centage was associated with a higher proportion of total
SM and lower proportion of total PC in the surface of
LDL particles (Fig. 4B), which were previously shown to
be characteristics of aggregation-prone LDL.21 High body
fat percentage was also associated with a high relative con-
tent of CE 18:2 and TAG 56:8 and low proportion of mono-
unsaturated CE species 16:1 and 18:1 in the core of LDL
particles. Notably, many of these LDL components were
associated in a similar manner with LDL aggregation
(Fig. 2). Moreover, some of these specific lipid species
that correlated positively with both LDL aggregation and
body fat percentage were present to a higher extent in
LDL of South Asians (SM 24:0 and TAG 56:8), and vice
versa, CE 18:1 with low levels in South Asians correlated
negatively with both LDL aggregation and body fat per-
centage (Fig. 2 vs Fig. 4B). Strikingly, the LDL lipid sur-
face proportion of many PCs (PC 38:5, PC 34:1, and PC
32:1) correlated negatively with body fat percentage and
were lower in South Asians than in white Caucasians.
When the groups were evaluated separately, higher total
SM and lower total PC content statistically significantly
correlated with a higher body fat percentage only in South
Asians but not in white Caucasians (Supplemental Fig. 2).Discussion
In this study, we show that South Asians, who have
higher ASCVD morbidity and mortality than white Cauca-
sians,4–6,33 have LDL that is more prone to aggregate than
LDL from white Caucasians. Recently, we showed that
increased LDL aggregation susceptibility is a marker of
increased ASCVD risk independently of conventional risk
factors.21 As aggregation of modified LDL is one of the
key steps in atherogenesis by promoting LDL reten-
tion,9,11,16 foam cell formation,34–36 inflammation,20 and
plaque destabilization,21 the presence of aggregation-
prone LDL, besides being a marker, can also be a maker
in several crucial steps in atherogenesis. Therefore, the un-
beneficial LDL quality among South Asians could partly
explain their increased risk for ASCVD compared with
white Caucasians.
The susceptibility of LDL to aggregation is influenced
by the lipid composition of the surface monolayer of LDL,
which, in turn, influences the conformation of apo-B100.21
Figure 4 (A) Correlation between LDL aggregation susceptibil-
ity and body fat percentage (r 5 0.486, P 5 .016). (B) Volcano
plot showing the Spearman correlation coefficients of body fat
percentage vs LDL lipids (n 5 24). Only those lipids with signif-
icant P-values (P , .05) are identified in the figure. Positive cor-
relations are indicated with red circles and negative correlations
with blue circles. CE, cholesteryl ester; LPC, lysophosphatidyl-
choline; LDL, low-density lipoprotein; PC, phosphatidylcholine;
SM, sphingomyelin; TAG; triacylglycerol.
Ruuth et al LDL aggregation and ethnicity 917Such conformational changes mediate formation of LDL
aggregates.15,21 In addition to the surface lipids, also the
core lipid composition has been identified to influence the
conformation of apoB-100 within LDL.37,38 We previously
showed that a high proportion of SM within the surface of
circulating LDL is associated with aggregation-prone LDL,
whereas a high proportion of PC is associated with
aggregation-resistant LDL. Moreover, causality of the dif-
ferences in the lipid composition in LDL aggregation was
previously shown by modifying the proportions of SM
and PC in vitro or in vivo in mice.21 In the present study,
we observed that the proportion SM 23:0 and SM 24:0
were higher in aggregation-prone LDL, which is thus inaccordance with our previous results. In addition, of the
core lipids, the proportion of highly unsaturated TAG
56:8 was higher in aggregation-prone LDL, whereas the
proportion of TAGs 52:2 and 54:1 and CEs 18:1 and 16:0
were higher in aggregation-resistant LDLs. In accordance,
TAGs and CEs harboring saturated and monosaturated fatty
acids in LDL were also previously shown to associate with
lower aggregation susceptibility of LDL particles.21
Of the individual lipid species that correlated with LDL
aggregation susceptibility, TAG 56:8 comprised largely of 2
main molecular species (16:0/18:2/22:6 and 16:0/20:4/
20:4) of which particularly the arachidonic acid (20:4)–
containing TAG species was higher in South Asians.
Furthermore, the LDL surface PC profile of the South
Asians was characterized by high proportion of PC 38:4
and PC 36:2, which also contained arachidonic acid or its
precursor linoleic acid (18:2), respectively. In line with
these findings, plasma levels of arachidonic acid have been
reported to be higher in South Asians than in white
Caucasians.39 Arachidonic acid can be converted intracellu-
larly into either proinflammatory or proresolving lipid me-
diators, whereas docosahexaenoic acid (22:6) is converted
into proresolving lipid mediators. The balance between
these proinflammatory and proresolving lipid mediators
controls the inflammatory state of an atherosclerotic pla-
que.40 We propose that LDL enriched in arachidonic
acid–containing TAGs and PCs species contributes to
increased LDL aggregation in South Asians.
We observed for the first time that body fat percentage
(mean 16.7%, range 8.2%-25.5%) correlated positively
with aggregation susceptibility of LDL particles. Thus, in
addition to having aggregation-prone LDL particles, South
Asians had a higher body fat percentage than white
Caucasians (18.9 6 3.2 vs. 14.5 6 4.7%) at a similar
BMI (24.7 6 2.7 vs. 23.9 6 2.4 kg/m2). This latter finding
is in accordance with previous reports.41,42 Of note, BMI is
a relatively poor predictor of body fat,43 and indeed, we did
not observe any association between BMI and LDL aggre-
gation in either this study or in our previous study co-
horts.21 When investigating the LDL lipidome in relation
to adiposity, we observed a positive correlation between
body fat percentage and total SM content of LDL particles
only in South Asians (Spearman’s rho 5 0.678, P 5 .014).
SMs are bioactive lipids that are modulated by adiposity, as
obesity-induced inflammation has been suggested to in-
crease SM biosynthesis, and SMs have the potential to in-
crease metabolic dysfunction and ASCVD risk.22,23,44 In
line with this, loss of visceral fat was recently associated
with a decrease in plasma SM levels and reduced inflamma-
tion in athletes with a healthy body weight.45 Furthermore,
similar changes in circulating SM levels and inflammation
status were observed during a 7-year follow-up period of
individuals who lost body weight, whereas opposite effects
were observed in individuals who gained weight.45 Indeed,
in addition to a higher body fat percentage in South Asians
compared with white Caucasians, the surface of LDL par-
ticles of South Asians was enriched in SM 24:0.
918 Journal of Clinical Lipidology, Vol 13, No 6, December 2019Collectively, these data support a link between being over-
weight and increased ASCVD risk,46,47 and we suggest that
adiposity may modulate the lipidome of LDL particles to
affect their aggregation susceptibility.
Limitations of the study
The sample size in this study is relatively small, and we
investigated LDL aggregation susceptibility in blood sam-
ples only from healthy subjects in a cross-sectional study.
Therefore, these results should be verified in larger study
cohorts, also including patients with ASCVD. In addition, it
would be highly interesting to investigate in a prospective
study setting whether the susceptibility of LDL particles to
aggregate indeed contributes to the development of ASCVD
particularly in South Asians. Dietary information of the
participants in this study is limited and the relative effects of
diet vs. body composition on LDL aggregation susceptibility
remain to be examined in future studies. In addition, the LDL
aggregation assay requires isolation of LDL particles, which
may challenge the clinical use of the assay and its use in large
cohorts. In the present study we found differences in the lipid
composition of LDL particles between South Asian and
white Caucasian participants. However, ethnicity may also
influence the apolipoproteins other than apoB-100 carried in
LDL particles. Such differences and their potential effect on
LDL aggregation remain to be studied.Conclusions
This study provides evidence that LDL aggregation
susceptibility is higher in young lean South Asians
compared with BMI-matched white Caucasians. Mechanis-
tically, this may be explained by the higher body fat
percentage of South Asians, leading to SM enrichment of
the LDL particle surface. We anticipate that the presence of
SM-rich and arachidonic acid-rich, aggregation-prone LDL
particles in young South Asians may increase LDL
accumulation in the arterial wall and thereby contribute
to their increased risk of developing ASCVD later in life.
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919.e1 Journal of Clinical Lipidology, Vol 13, No 6, December 2019AppendixSupplementary Table 1 LDL lipids that differ significantly between white Caucasians and South Asians
LDL Surface Lipids White Caucasians (mean % of lipid class) South Asians (mean % of lipid class) P-value
LPC 16:0 50.20 6 3.85 46.75 6 4.23 .048
LPC 20:3 0.80 6 0.41 0.38 6 0.27 .008
PC 32:1 0.61 6 0.40 0.28 6 0.18 .020
PC 34:1 11.47 6 1.74 8.83 6 1.58 .001
PC 34:1 alkyl 0.57 6 0.10 0.47 6 0.08 .012
PC 36:1 alkyl 0.26 6 0.04 0.20 6 0.07 .020
PC 36:2 14.02 6 1.46 15.44 6 1.75 .042
PC 36:5 1.21 6 0.36 0.84 6 0.29 .019
PC 38:4 5.94 6 0.79 6.92 6 1.14 .023
PC 38:5 2.95 6 0.36 2.37 6 0.57 .008
SM 23:1 3.40 6 0.39 3.00 6 0.51 .045
SM 24:0 6.50 6 0.83 7.75 6 1.44 .018
LDL core lipids
CE 16:1 1.7 6 0.6 0.9 6 0.6 ,.001
CE 18:1 6.2 6 1.8 3.9 6 1.5 .001
CE 18:2 66.5 6 4.7 69.9 6 3.5 .040
TAG 52:2 14.2 6 2.1 11.5 6 2.4 .011
TAG 56:8 0.67 6 0.24 0.90 6 0.26 .029
CE, cholesteryl ester; LPC, lysophosphatidylcholine; PC, phosphatidylcholine; TAG; triacylglycerol.
LDL lipids are expressed as mean percentages per lipid class (mean 6 SD, n 5 12 per group). Statistical differences between the groups were deter-
mined using the unpaired Student’s t-test. The difference in LPC 16:0, PC 36:2, SM 23:1, and SM 24:0 did not remain significant after FDR correction.Supplementary Figure 1 Volcano plot showing the Spearman correlation coefficients of LDL aggregate size at 2 h (LDL aggregation
susceptibility) vs LDL lipids in (A) South Asians (n 5 12) and (B) white Caucasians (n 5 12). Only those lipids with significant P-values
(P, .05) are annotated within the figure. Positive correlations are indicated with red circles, and negative correlations with blue circles. CE,
cholesteryl ester; LPC lysophosphatidylcholine; PC phosphatidylcholine; SM, sphingomyelin; TAG; triacylglycerol.
Supplementary Figure 2 Volcano plot showing the Spearman correlation coefficients of body fat percentages vs LDL lipids in (A) South
Asians (n 5 12) and (B) white Caucasians (n 5 12). Only those lipids with significant P-values (P , .05) are annotated within the figure.
Positive correlations are indicated with red circles, and negative correlations with blue circles. CE, cholesteryl ester; LPC, lysophosphati-
dylcholine; PC phosphatidylcholine; SM, sphingomyelin; TAG; triacylglycerol.
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